Breaking News Instant updates and real-time market news.

$COMP

Nasdaq Composite

/

+

08:24
10/05/22
10/05
08:24
10/05/22
08:24

Nasdaq Composite: Pivot points

The following are the pivot points for the . Pivot High: 11256.145, Pivot Low: 11110.225. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

OTHER BREAKING NEWS FROM THE FLY

Downgrade
Primary Health Properties downgraded to Underweight from Overweight at Barclays » 06:19
12/01/22
12/01
06:19
12/01/22
06:19
PHPRF

Primary Health Properties

$1.23 /

+ (+0.00%)

Barclays analyst Kanad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PHPRF Primary Health Properties
$1.23 /

+ (+0.00%)

07/05/22 Barclays
Primary Health Properties price target lowered to 140 GBp from 160 GBp at Barclays
04/28/22 Stifel
Primary Health Properties downgraded to Hold from Buy at Stifel
Initiation
Brunello Cucinelli initiated with a Buy at UBS » 06:18
12/01/22
12/01
06:18
12/01/22
06:18
BCUCY

Brunello Cucinelli

$32.31 /

+ (+0.00%)

UBS analyst Chris Huang…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BCUCY Brunello Cucinelli
$32.31 /

+ (+0.00%)

10/20/22 Deutsche Bank
Brunello Cucinelli price target raised to EUR 48 from EUR 46 at Deutsche Bank
10/20/22 Societe Generale
Brunello Cucinelli price target raised to EUR 37 from EUR 34 at Societe Generale
10/20/22 Jefferies
Brunello Cucinelli upgraded to Buy from Hold at Jefferies
08/02/22 Deutsche Bank
Brunello Cucinelli price target raised to EUR 46 from EUR 34 at Deutsche Bank
Downgrade
Leslie's downgraded to Hold from Buy at Stifel » 06:16
12/01/22
12/01
06:16
12/01/22
06:16
LESL

Leslie's

$14.61 /

-0.475 (-3.15%)

Stifel analyst W. Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LESL Leslie's
$14.61 /

-0.475 (-3.15%)

LESL Leslie's
$14.61 /

-0.475 (-3.15%)

11/28/22 Stifel
Leslie's price target lowered to $17 from $20 at Stifel
11/15/22 Baird
Leslie's downgraded to Neutral from Outperform at Baird
10/03/22 MKM Partners
MKM Partners starts Leslie's at Neutral, sees higher costs impact profitability
10/03/22 MKM Partners
Leslie's initiated with a Neutral at MKM Partners
LESL Leslie's
$14.61 /

-0.475 (-3.15%)

  • 15
    Dec
LESL Leslie's
$14.61 /

-0.475 (-3.15%)

LESL Leslie's
$14.61 /

-0.475 (-3.15%)

Upgrade
Lennox upgraded to Overweight from Equal Weight at Wells Fargo » 06:15
12/01/22
12/01
06:15
12/01/22
06:15
LII

Lennox

$259.94 /

-1 (-0.38%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LII Lennox
$259.94 /

-1 (-0.38%)

LII Lennox
$259.94 /

-1 (-0.38%)

11/01/22 JPMorgan
Lennox upgraded to Neutral from Underweight at JPMorgan
10/31/22 Wells Fargo
Lennox price target lowered to $238 from $249 at Wells Fargo
10/13/22 Deutsche Bank
Lennox price target lowered to $287 from $302 at Deutsche Bank
10/13/22 Deutsche Bank
Lennox named short-term buy idea at Deutsche Bank
LII Lennox
$259.94 /

-1 (-0.38%)

LII Lennox
$259.94 /

-1 (-0.38%)

Initiation
GoodRx initiated with a Buy at Citi » 06:14
12/01/22
12/01
06:14
12/01/22
06:14
GDRX

GoodRx

$4.35 /

-0.09 (-2.03%)

Citi analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GDRX GoodRx
$4.35 /

-0.09 (-2.03%)

GDRX GoodRx
$4.35 /

-0.09 (-2.03%)

11/10/22 Deutsche Bank
GoodRx price target lowered to $7 from $9 at Deutsche Bank
11/04/22 JPMorgan
GoodRx upgraded to Neutral from Underweight at JPMorgan
10/11/22 Barclays
GoodRx price target lowered to $9 from $13 at Barclays
09/15/22 KeyBanc
GoodRx initiated with a Sector Weight at KeyBanc
GDRX GoodRx
$4.35 /

-0.09 (-2.03%)

GDRX GoodRx
$4.35 /

-0.09 (-2.03%)

GDRX GoodRx
$4.35 /

-0.09 (-2.03%)

Recommendations
Salesforce price target lowered to $185 from $200 at Oppenheimer » 06:13
12/01/22
12/01
06:13
12/01/22
06:13
CRM

Salesforce

$159.94 /

+8.22 (+5.42%)

Oppenheimer analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$159.94 /

+8.22 (+5.42%)

CRM Salesforce
$159.94 /

+8.22 (+5.42%)

11/29/22 KeyBanc
Salesforce price target lowered to $200 from $210 at KeyBanc
11/29/22 Baird
Salesforce price target lowered to $210 from $230 at Baird
11/28/22 Evercore ISI
Salesforce price target lowered to $200 from $225 at Evercore ISI
11/28/22 Stifel
Salesforce price target lowered to $185 from $200 at Stifel
CRM Salesforce
$159.94 /

+8.22 (+5.42%)

CRM Salesforce
$159.94 /

+8.22 (+5.42%)

CRM Salesforce
$159.94 /

+8.22 (+5.42%)

CRM Salesforce
$159.94 /

+8.22 (+5.42%)

Recommendations
Correction: Hub Group not downgraded today at Wolfe Research  06:13
12/01/22
12/01
06:13
12/01/22
06:13
HUBG

Hub Group

$84.14 /

+1.29 (+1.56%)

 
ShowHide Related Items >><<
HUBG Hub Group
$84.14 /

+1.29 (+1.56%)

HUBG Hub Group
$84.14 /

+1.29 (+1.56%)

11/17/22 Wolfe Research
Wolfe reshuffles ratings in freight with five downgrades and one upgrade
11/17/22 Wolfe Research
Hub Group downgraded to Peer Perform from Outperform at Wolfe Research
10/11/22 Barclays
Hub Group price target lowered to $75 from $82 at Barclays
08/10/22 Susquehanna
Hub Group price target raised to $117 from $115 at Susquehanna
HUBG Hub Group
$84.14 /

+1.29 (+1.56%)

Syndicate
Abeona Therapeutics files to sell 15.2M shares of common stock for holders  06:12
12/01/22
12/01
06:12
12/01/22
06:12
ABEO

Abeona Therapeutics

$3.77 /

-0.06 (-1.57%)

 
ShowHide Related Items >><<
ABEO Abeona Therapeutics
$3.77 /

-0.06 (-1.57%)

ABEO Abeona Therapeutics
$3.77 /

-0.06 (-1.57%)

11/08/22 Cantor Fitzgerald
Abeona Therapeutics price target raised to $40 from $22 at Cantor Fitzgerald
11/04/22 Alliance Global Partners
Abeona's EB-101 results 'dramatically positive,' says Alliance Global Partners
09/15/22 Alliance Global Partners
Abeona Therapeutics initiated with a Buy at Alliance Global Partners
08/11/22 Cantor Fitzgerald
Abeona Therapeutics price target raised to $22 from $15 at Cantor Fitzgerald
ABEO Abeona Therapeutics
$3.77 /

-0.06 (-1.57%)

  • 17
    Dec
Periodicals
Amazon CEO Jassy doesn't regret hiring spree as layoffs begin, WSJ reports » 06:12
12/01/22
12/01
06:12
12/01/22
06:12
AMZN

Amazon.com

$96.50 /

+4.1 (+4.44%)

Amazon CEO Andy Jassy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

11/30/22 JMP Securities
JMP Securities encouraged by Amazon.com's focus on innovation
11/29/22 UBS
Affirm initiated with a Neutral at UBS
11/22/22 Piper Sandler
Amazon.com price target lowered to $119 from $125 at Piper Sandler
11/21/22 JPMorgan
JPMorgan more cautious on online holiday sales, Amazon still top idea
AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

Periodicals
CEO Jassy says Amazon has no plans to remove anti-Semitic film, NY Times report » 06:12
12/01/22
12/01
06:12
12/01/22
06:12
AMZN

Amazon.com

$96.50 /

+4.1 (+4.44%)

Amazon CEO Andy Jassy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

11/30/22 JMP Securities
JMP Securities encouraged by Amazon.com's focus on innovation
11/29/22 UBS
Affirm initiated with a Neutral at UBS
11/22/22 Piper Sandler
Amazon.com price target lowered to $119 from $125 at Piper Sandler
11/21/22 JPMorgan
JPMorgan more cautious on online holiday sales, Amazon still top idea
AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

Syndicate
Iveric bio 13.35M share Spot Secondary priced at $22.50 » 06:12
12/01/22
12/01
06:12
12/01/22
06:12
ISEE

Iveric bio

$23.60 /

+0.77 (+3.37%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ISEE Iveric bio
$23.60 /

+0.77 (+3.37%)

ISEE Iveric bio
$23.60 /

+0.77 (+3.37%)

11/10/22 Jefferies
Apellis downgraded to Hold at Jefferies after doctor survey
11/10/22 Jefferies
Iveric bio downgraded to Hold at Jefferies after doctor survey
11/10/22 Jefferies
Iveric bio downgraded to Hold from Buy at Jefferies
10/17/22 B. Riley
Iveric bio upgraded to Neutral at B. Riley after competitor in GA 'disappoints'
ISEE Iveric bio
$23.60 /

+0.77 (+3.37%)

  • 01
    Dec
ISEE Iveric bio
$23.60 /

+0.77 (+3.37%)

ISEE Iveric bio
$23.60 /

+0.77 (+3.37%)

Initiation
ADT Inc. resumed with a Buy at Citi » 06:11
12/01/22
12/01
06:11
12/01/22
06:11
ADT

ADT Inc.

$9.34 /

+0.135 (+1.47%)

Citi analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADT ADT Inc.
$9.34 /

+0.135 (+1.47%)

ADT ADT Inc.
$9.34 /

+0.135 (+1.47%)

10/31/22 Morgan Stanley
ADT Inc. resumed with an Equal Weight at Morgan Stanley
01/06/22 RBC Capital
ADT Inc. downgraded to Sector Perform at RBC Capital on free cash flow headwinds
01/06/22 RBC Capital
ADT Inc. downgraded to Sector Perform from Outperform at RBC Capital
01/05/22 Citi
ADT Inc. resumed with a Buy at Citi
ADT ADT Inc.
$9.34 /

+0.135 (+1.47%)

ADT ADT Inc.
$9.34 /

+0.135 (+1.47%)

ADT ADT Inc.
$9.34 /

+0.135 (+1.47%)

ADT ADT Inc.
$9.34 /

+0.135 (+1.47%)

Hot Stocks
Bank of Montreal raises quarterly dividend 3% to C$1.43 per share » 06:11
12/01/22
12/01
06:11
12/01/22
06:11
BMO

Bank of Montreal

$97.83 /

+1.73 (+1.80%)

The dividend on the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMO Bank of Montreal
$97.83 /

+1.73 (+1.80%)

BMO Bank of Montreal
$97.83 /

+1.73 (+1.80%)

11/22/22 Scotiabank
Bank of Montreal price target lowered to C$156 from C$159 at Scotiabank
11/18/22 National Bank
Bank of Montreal price target lowered to C$147 from C$151 at National Bank
09/01/22 Desjardins
Bank of Montreal price target lowered to C$150 from C$153 at Desjardins
09/01/22 Canaccord
Bank of Montreal price target lowered to C$150.50 from C$152.50 at Canaccord
BMO Bank of Montreal
$97.83 /

+1.73 (+1.80%)

BMO Bank of Montreal
$97.83 /

+1.73 (+1.80%)

Recommendations
Okta price target lowered to $85 from $95 at Oppenheimer » 06:11
12/01/22
12/01
06:11
12/01/22
06:11
OKTA

Okta

$53.31 /

+2.06 (+4.02%)

Oppenheimer analyst Ittai…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OKTA Okta
$53.31 /

+2.06 (+4.02%)

OKTA Okta
$53.31 /

+2.06 (+4.02%)

11/29/22 Jefferies
Okta risk/reward attractive amid low expectations, says Jefferies
11/22/22 Piper Sandler
Okta price target lowered to $80 from $125 at Piper Sandler
11/14/22 Canaccord
Okta price target lowered to $70 from $85 at Canaccord
11/14/22 JMP Securities
Okta price target lowered to $105 from $145 at JMP Securities
OKTA Okta
$53.31 /

+2.06 (+4.02%)

OKTA Okta
$53.31 /

+2.06 (+4.02%)

OKTA Okta
$53.31 /

+2.06 (+4.02%)

OKTA Okta
$53.31 /

+2.06 (+4.02%)

Earnings
Bank of Montreal reports Q4 adjusted EPS C$3.04 vs. C$3.33 a year ago » 06:10
12/01/22
12/01
06:10
12/01/22
06:10
BMO

Bank of Montreal

$97.83 /

+1.73 (+1.80%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMO Bank of Montreal
$97.83 /

+1.73 (+1.80%)

BMO Bank of Montreal
$97.83 /

+1.73 (+1.80%)

11/22/22 Scotiabank
Bank of Montreal price target lowered to C$156 from C$159 at Scotiabank
11/18/22 National Bank
Bank of Montreal price target lowered to C$147 from C$151 at National Bank
09/01/22 Desjardins
Bank of Montreal price target lowered to C$150 from C$153 at Desjardins
09/01/22 Canaccord
Bank of Montreal price target lowered to C$150.50 from C$152.50 at Canaccord
BMO Bank of Montreal
$97.83 /

+1.73 (+1.80%)

BMO Bank of Montreal
$97.83 /

+1.73 (+1.80%)

Syndicate
Intellia Therapeutics 6.55M share Spot Secondary priced at $45.80 » 06:10
12/01/22
12/01
06:10
12/01/22
06:10
NTLA

Intellia Therapeutics

$51.41 /

+3.44 (+7.17%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

11/14/22 Chardan
Intellia Therapeutics price target raised to $129 from $121 at Chardan
11/03/22 Chardan
Intellia Therapeutics price target lowered to $121 from $146 at Chardan
10/31/22 EF Hutton
Intellia Therapeutics initiated with a Buy at EF Hutton
10/11/22 Morgan Stanley
Intellia Therapeutics initiated with an Overweight at Morgan Stanley
NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

  • 01
    Dec
NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

Recommendations
Elastic price target lowered to $90 from $110 at Oppenheimer » 06:10
12/01/22
12/01
06:10
12/01/22
06:10
ESTC

Elastic

$61.16 /

+2.16 (+3.66%)

Oppenheimer analyst Ittai…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ESTC Elastic
$61.16 /

+2.16 (+3.66%)

ESTC Elastic
$61.16 /

+2.16 (+3.66%)

11/18/22 Barclays
Elastic price target lowered to $80 from $85 at Barclays
10/26/22 Truist
Elastic price target lowered to $95 from $105 at Truist
10/19/22 Baird
Elastic assumed with an Outperform at Baird
10/18/22 Barclays
Elastic price target lowered to $85 from $105 at Barclays
ESTC Elastic
$61.16 /

+2.16 (+3.66%)

ESTC Elastic
$61.16 /

+2.16 (+3.66%)

ESTC Elastic
$61.16 /

+2.16 (+3.66%)

Hot Stocks
Wallbox appoints new Chief Communications and Public Affairs Officer, CMO » 06:10
12/01/22
12/01
06:10
12/01/22
06:10
WBX

Wallbox

$5.59 /

+0.24 (+4.49%)

Wallbox announced two…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WBX Wallbox
$5.59 /

+0.24 (+4.49%)

WBX Wallbox
$5.59 /

+0.24 (+4.49%)

11/22/22 Northland
Wallbox initiated with an Outperform at Northland
11/10/22 Canaccord
Wallbox price target lowered to $13 from $14 at Canaccord
11/10/22 Baird
Wallbox price target lowered to $14 from $20 at Baird
09/07/22 Credit Suisse
Wallbox initiated with an Outperform at Credit Suisse
WBX Wallbox
$5.59 /

+0.24 (+4.49%)

Recommendations
Portage Biotech price target lowered to $21 from $22 at H.C. Wainwright » 06:09
12/01/22
12/01
06:09
12/01/22
06:09
PRTG

Portage Biotech

$5.75 /

-0.15 (-2.54%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRTG Portage Biotech
$5.75 /

-0.15 (-2.54%)

PRTG Portage Biotech
$5.75 /

-0.15 (-2.54%)

11/30/22 Cantor Fitzgerald
Portage Biotech price target lowered to $18 from $26 at Cantor Fitzgerald
11/30/22 Oppenheimer
Portage Biotech price target lowered to $18 from $26 at Oppenheimer
09/20/22 H.C. Wainwright
Portage Biotech price target lowered to $22 from $32 at H.C. Wainwright
07/15/22 Oppenheimer
Portage Biotech assumed with an Outperform at Oppenheimer
PRTG Portage Biotech
$5.75 /

-0.15 (-2.54%)

PRTG Portage Biotech
$5.75 /

-0.15 (-2.54%)

PRTG Portage Biotech
$5.75 /

-0.15 (-2.54%)

Initiation
Viridian Therapeutics initiated with a Buy at H.C. Wainwright » 06:09
12/01/22
12/01
06:09
12/01/22
06:09
VRDN

Viridian Therapeutics

$25.22 /

+2.37 (+10.37%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRDN Viridian Therapeutics
$25.22 /

+2.37 (+10.37%)

VRDN Viridian Therapeutics
$25.22 /

+2.37 (+10.37%)

10/14/22 Evercore ISI
Viridian Therapeutics added to 'TAP Outperform' list at Evercore ISI
08/16/22 B. Riley
Viridian Therapeutics price target raised to $40 from $25 at B. Riley
08/15/22 Evercore ISI
Viridian Therapeutics price target raised to $50 from $40 at Evercore ISI
06/23/22 B. Riley
B. Riley starts Viridian Therapeutics at Buy with $25 price target
VRDN Viridian Therapeutics
$25.22 /

+2.37 (+10.37%)

  • 17
    Aug
VRDN Viridian Therapeutics
$25.22 /

+2.37 (+10.37%)

Hot Stocks
Sempra Energy subsidiary enters SPA with Ineos for LNG supply » 06:08
12/01/22
12/01
06:08
12/01/22
06:08
SRE

Sempra Energy

$166.28 /

+4.865 (+3.01%)

Sempra Infrastructure, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRE Sempra Energy
$166.28 /

+4.865 (+3.01%)

SRE Sempra Energy
$166.28 /

+4.865 (+3.01%)

10/24/22 Guggenheim
Sempra Energy price target lowered to $165 from $174 at Guggenheim
10/03/22 Mizuho
Sempra Energy price target lowered to $161 from $173 at Mizuho
09/15/22 Wells Fargo
Sempra Energy price target raised to $189 from $184 at Wells Fargo
07/18/22 Barclays
Sempra Energy price target lowered to $176 from $186 at Barclays
SRE Sempra Energy
$166.28 /

+4.865 (+3.01%)

SRE Sempra Energy
$166.28 /

+4.865 (+3.01%)

SRE Sempra Energy
$166.28 /

+4.865 (+3.01%)

Downgrade
Allianz downgraded to Neutral from Outperform at Exane BNP Paribas » 06:08
12/01/22
12/01
06:08
12/01/22
06:08
ALIZY

Allianz

$21.35 /

+0.13 (+0.61%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALIZY Allianz
$21.35 /

+0.13 (+0.61%)

ALIZY Allianz
$21.35 /

+0.13 (+0.61%)

11/14/22 Berenberg
Allianz price target raised to EUR 271 from EUR 267 at Berenberg
11/11/22 JPMorgan
Allianz price target raised to EUR 220 from EUR 210 at JPMorgan
10/21/22 Barclays
Allianz price target lowered to EUR 205 from EUR 214 at Barclays
10/19/22 JPMorgan
Allianz price target lowered to EUR 210 from EUR 220 at JPMorgan
Downgrade
SQZ Biotechnologies downgraded to Underperform from Buy at BofA » 06:08
12/01/22
12/01
06:08
12/01/22
06:08
SQZ

SQZ Biotechnologies

$2.51 /

+0.02 (+0.80%)

BofA analyst Tazeen Ahmad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SQZ SQZ Biotechnologies
$2.51 /

+0.02 (+0.80%)

SQZ SQZ Biotechnologies
$2.51 /

+0.02 (+0.80%)

10/20/22 H.C. Wainwright
SQZ Biotechnologies initiated with a Buy at H.C. Wainwright
10/06/22 BTIG
SQZ Biotechnologies price target lowered to $15 from $40 at BTIG
05/25/22 Chardan
SQZ Biotechnologies initiated with Buy, $17 target at Chardan
05/25/22 Chardan
SQZ Biotechnologies initiated with a Buy at Chardan
SQZ SQZ Biotechnologies
$2.51 /

+0.02 (+0.80%)

Initiation
Sapiens initiated with an Underweight at JPMorgan » 06:06
12/01/22
12/01
06:06
12/01/22
06:06
SPNS

Sapiens

$19.46 /

+0.21 (+1.09%)

JPMorgan analyst Alexei…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPNS Sapiens
$19.46 /

+0.21 (+1.09%)

SPNS Sapiens
$19.46 /

+0.21 (+1.09%)

08/08/22 Citi
Sapiens price target lowered to $25 from $27 at Citi
02/24/22 Citi
Sapiens price target lowered to $30 from $38 at Citi
12/14/21 JPMorgan
Sapiens downgraded to Underweight from Neutral at JPMorgan
12/14/21 JPMorgan
Sapiens downgraded to Underweight from Neutral at JPMorgan
SPNS Sapiens
$19.46 /

+0.21 (+1.09%)

Downgrade
Zebra Technologies downgraded to Underperform from Peer Perform at Wolfe Research » 06:06
12/01/22
12/01
06:06
12/01/22
06:06
ZBRA

Zebra Technologies

$270.15 /

+3.36 (+1.26%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZBRA Zebra Technologies
$270.15 /

+3.36 (+1.26%)

ZBRA Zebra Technologies
$270.15 /

+3.36 (+1.26%)

11/03/22 UBS
Zebra Technologies price target lowered to $445 from $485 at UBS
11/02/22 Needham
Zebra Technologies price target lowered to $330 from $450 at Needham
11/02/22 Baird
Zebra Technologies price target lowered to $300 from $330 at Baird
10/14/22 Morgan Stanley
Zebra Technologies price target lowered to $225 from $335 at Morgan Stanley
ZBRA Zebra Technologies
$270.15 /

+3.36 (+1.26%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.